SPERO THERAPEUTICS INC (SPRO) Stock Balance Sheet
USA - NASDAQ:SPRO - US84833T1034 - Common Stock
1.9 USD
-0.05 (-2.56%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 31.19M | 52.89M | 76.33M | 109.10M | 112.60M | |||
| Marketable Securities | N/A | N/A | N/A | 0.00 | 33.80M | |||
| Receivables | 26.91M | 52.48M | 50.70M | 1.10M | 2.60M | |||
| Other Current Assets | 1.29M | 1.91M | 4.18M | 3.40M | 8.80M | |||
| Total Current Assets | 59.40M | 107.28M | 131.21M | 113.60M | 157.90M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.56M | 3.11M | 4.16M | 5.50M | 7.60M | |||
| Other Non-Current Assets | 153.00K | 153.00K | 435.00K | 5.70M | 5.60M | |||
| Total Non-Current Assets | 2.72M | 3.27M | 51.18M | 11.20M | 13.20M | |||
| TOTAL ASSETS | 62.12M | 110.54M | 182.39M | 124.80M | 171.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 8.57M | 19.47M | 8.28M | 10.70M | 15.70M | |||
| Accounts Payable | 780.00K | 7.31M | 1.38M | 600.00K | 1.10M | |||
| Other Current Liabilities | 5.59M | 22.30M | 27.50M | 10.40M | 1.90M | |||
| Total Current Liabilities | 14.95M | 49.07M | 37.15M | 21.60M | 18.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 48.40M | |||
| Other Non-Current Liabilities | 14.35M | 15.35M | 38.34M | 27.20M | 15.70M | |||
| Total Non-Current Liabilities | 14.35M | 15.35M | 38.34M | 27.30M | 64.10M | |||
| TOTAL LIABILITIES | 29.29M | 64.42M | 75.50M | 48.90M | 82.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -475.20M | -459.64M | -391.07M | -413.90M | -367.50M | |||
| Additional Paid In Capital | 507.98M | 505.71M | 497.91M | 489.80M | 455.70M | |||
| Minority Interest | N/A | N/A | N/A | N/A | N/A | |||
| Common Shares | 56.00K | 55.00K | 53.00K | 100.00K | 0.00 | |||
| Other Shareholders' Equity | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 56.19M | 54.59M | 53.00M | 52.50M | 32.40M | |||
| Tangible Book Value per Share | 0.58 | 0.84 | 2.02 | 1.45 | 2.73 | |||
| Total Shareholders' Equity | 32.83M | 46.12M | 106.89M | 75.90M | 88.30M | |||
| TOTAL LIABILITIES AND EQUITY | 62.12M | 110.54M | 182.39M | 124.80M | 171.10M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | 0.55 | |||
| Current Ratio | 3.97 | 2.19 | 3.53 | 5.26 | 8.44 | |||
| Return On Assets (ROA) | -86.29% | -62.03% | 12.50% | -37.20% | -52.46% | |||
| Return On Equity (ROE) | -163.28% | -148.66% | 21.34% | -61.16% | -101.65% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | 14.57% | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | 30.71% | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | 30.71% | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21